These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

952 related items for PubMed ID: 26577767

  • 1. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Norero E, Bustos M, Herrera ME, Cerda J, González P, Ceroni M, Martínez C, Briceño E, Rojas H, Cártes R, Lopez V, Hidalgo V, Báez S, Caracci M, Viñuela E, Díaz A.
    Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
    [Abstract] [Full Text] [Related]

  • 2. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G, Aurello P, D'Angelo F, Cicchini C, Sternberg CN.
    Hepatogastroenterology; 2000 Jan; 47(35):1470-4. PubMed ID: 11100379
    [Abstract] [Full Text] [Related]

  • 3. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM, Koo J, Miloro SM, Driscoll DL, Nava HR, Douglass HO.
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [Abstract] [Full Text] [Related]

  • 4. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide, Lin D, Li Y, Xu H, Chen J, Wang B, Liu C, Lu P.
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [Abstract] [Full Text] [Related]

  • 5. Hepatic resection for synchronous hepatic metastasis from gastric cancer.
    Qiu JL, Deng MG, Li W, Zou RH, Li BK, Zheng Y, Lao XM, Zhou K, Yuan YF.
    Eur J Surg Oncol; 2013 Jul; 39(7):694-700. PubMed ID: 23579173
    [Abstract] [Full Text] [Related]

  • 6. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile?
    Yildirim E, Celen O, Berberoglu U.
    J Am Coll Surg; 2001 Jan; 192(1):25-37. PubMed ID: 11192920
    [Abstract] [Full Text] [Related]

  • 7. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.
    Memon MA, Subramanya MS, Khan S, Hossain MB, Osland E, Memon B.
    Ann Surg; 2011 May; 253(5):900-11. PubMed ID: 21394009
    [Abstract] [Full Text] [Related]

  • 8. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
    Di Martino N, Izzo G, Cosenza A, Vicenzo L, Monaco L, Torelli F, Basciotti A, Brillantino A, Marra A.
    Suppl Tumori; 2005 May; 4(3):S84-5. PubMed ID: 16437920
    [Abstract] [Full Text] [Related]

  • 9. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
    In H, Kantor O, Sharpe SM, Baker MS, Talamonti MS, Posner MC.
    Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
    [Abstract] [Full Text] [Related]

  • 10. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J, Mattila A, Böhm J, Jantunen I, Kellokumpu I.
    World J Gastroenterol; 2015 Dec 21; 21(47):13294-301. PubMed ID: 26715812
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
    Leong CN, Chung HT, Lee KM, Shakespeare TP, Mukherjee RK, Wong LC, Lu JJ, Tey J, Lim R, So JB, Back MF.
    Cancer J; 2008 Dec 21; 14(4):269-75. PubMed ID: 18677137
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J, Cao B, Wang Y, Xiao A, Qin J, Wu J, Yan Q, Hu Y, Yang C, Cao Z, Hu J, Yin P, Xie D, Gong J.
    Trials; 2018 Aug 09; 19(1):432. PubMed ID: 30092843
    [Abstract] [Full Text] [Related]

  • 14. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
    Wu H, Wang L, He YL, Xu JB, Cai SR, Ma JP, Chen CQ, Zhang XH, Zhan WH.
    Zhonghua Zhong Liu Za Zhi; 2013 Jul 09; 35(7):509-13. PubMed ID: 24257302
    [Abstract] [Full Text] [Related]

  • 15. [Adjuvant chemo radiotherapy after gastrectomy and D2 lymphadenectomy in patients with gastric cancer in the National Institute of Cancer, Lima, Peru].
    Montenegro P, Flores L, Quintana S, Casanova L, Ruíz E, León J, Mantilla R.
    Rev Gastroenterol Peru; 2013 Jul 09; 33(1):34-8. PubMed ID: 23539054
    [Abstract] [Full Text] [Related]

  • 16. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
    Ramos MFKP, Pereira MA, Dias AR, Yagi OK, Zaidan EP, Ribeiro-Júnior U, Zilberstein B, Cecconello I.
    Eur J Surg Oncol; 2019 Mar 09; 45(3):460-465. PubMed ID: 30497814
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection.
    Biffi R, Botteri E, Cenciarelli S, Luca F, Pozzi S, Valvo M, Sonzogni A, Chiappa A, Leal Ghezzi T, Rotmensz N, Bagnardi V, Andreoni B.
    Eur J Surg Oncol; 2011 Apr 09; 37(4):305-11. PubMed ID: 21288685
    [Abstract] [Full Text] [Related]

  • 20. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
    Cho BC, Jeung HC, Choi HJ, Rha SY, Hyung WJ, Cheong JH, Noh SH, Chung HC.
    J Surg Oncol; 2007 May 01; 95(6):461-8. PubMed ID: 17192913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.